Gavillet, Helen
Hatfield, Lauren
Jones, Andrew
Maitra, Anirban
Horsley, Alexander
Rivett, Damian
van der Gast, Christopher
Funding for this research was provided by:
Cystic Fibrosis Trust (VIA 045, VIA 045, VIA 045, VIA 045)
National Institute for Health and Care Research (CS012–13, CS012–13, CS012–13)
Article History
Received: 10 July 2023
Accepted: 22 February 2024
First Online: 25 March 2024
Declarations
:
: Patients or parents/guardians provided written informed consent and children provided assent. This study was reviewed and approved by the NHS Research Ethics Committee North-West, Lancaster (Ref 14/NW/1195).
: Not applicable.
: Outside of the submitted work, CvdG and DR report grants from Vertex Pharmaceuticals, and AH reports personal fees for advisory services (Vertex Pharmaceuticals, Roche Genentech, Boehringer Ingelheim) and for educational and presentation activities (Vertex Pharmaceuticals)